Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer

Prager, M.D., Gerald; taieb, julien; Fakih, Marwan; Ciardiello, Fortunato; Van Cutsem, Eric; Elez, Elena

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Prager, M.D., Gerald
dc.contributor.author	taieb, julien
dc.contributor.author	Fakih, Marwan
dc.contributor.author	Ciardiello, Fortunato
dc.contributor.author	Van Cutsem, Eric
dc.contributor.author	Elez, Elena
dc.date.accessioned	2024-11-22T07:17:47Z
dc.date.available	2024-11-22T07:17:47Z
dc.date.issued	2024
dc.identifier.citation	Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Élez E, et al. Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer. Futur Oncol. 2024;20(36):2823–32.
dc.identifier.issn	1744-8301
dc.identifier.uri	https://hdl.handle.net/11351/12255
dc.description	Colorectal; Metastasis; Refractory
dc.language.iso	eng
dc.publisher	Taylor & Francis
dc.relation.ispartofseries	Future Oncology;20(36)
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Avaluació de resultats (Assistència sanitària)
dc.subject	Quimioteràpia combinada
dc.subject	Medicaments antineoplàstics - Ús terapèutic
dc.subject	Recte - Càncer - Tractament
dc.subject	Còlon - Càncer - Tractament
dc.subject.mesh	Treatment Outcome
dc.subject.mesh	Colorectal Neoplasms
dc.subject.mesh	/drug therapy
dc.subject.mesh	Antineoplastic Combined Chemotherapy Protocols
dc.title	Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1080/14796694.2024.2366100
dc.subject.decs	resultado del tratamiento
dc.subject.decs	neoplasias colorrectales
dc.subject.decs	/farmacoterapia
dc.subject.decs	protocolos de quimioterapia antineoplásica combinada
dc.relation.publishversion	https://doi.org/10.1080/14796694.2024.2366100
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Prager GW] The Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. [Taieb J] The Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, SIRIC Cancer Research for Personalized Medicine, Université Paris Cité, Paris, France. [Fakih M] City of Hope Comprehensive Cancer Center, Duarte, CA, USA. [Ciardiello F] Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy. [Van Cutsem E] The Department of Digestive Oncology, University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium. [Élez E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. International Oncology Bureau-Quiron, Barcelona, Spain
dc.identifier.pmid	38953855
dc.identifier.wos	001261075800001
dc.rights.accessrights	info:eu-repo/semantics/openAccess